Cancer Related Content
Drug for ovarian cancer shows 52% reduction in death
Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.
Scientists discover new treatment to fight pancreatic cancer
The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.
Prospects for minimally invasive and optimally effective cancer immunotherapy
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
Drug gives 34% protection against lung cancer recurrence
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
Has COVID-19 impacted physicians who care for children with cancer?
Research reveals a global link between COVID-19 and the capacity of paediatric oncology health professionals to provide high quality care.
New blood test identifies metastatic status of cancer
A new minimally invasive and inexpensive blood test can detect a range of cancers in patients with non-specific symptoms, and can indicate whether the cancer has spread.
Getting personal in brain tumour therapy: Matching therapies to patients
Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field
A PinPoint solution to harnessing the power of AI in cancer diagnostics
PinPoint Data Science addresses the acute challenges of cancer diagnostics in the post-COVID NHS. Could their innovative machine learning platform be the low-cost, high-impact solution UK healthcare needs?
Contemporary immunology and its relationship to medicine
Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions
AI & digital transformation in cancer care
Artificial intelligence and digital transformation play an important role in improving cancer diagnosis, treatments and increasing cancer survival rates, writes Dee Mathieson, Senior Vice President Linac Service and Managing Director of Elekta Ltd.
How can next-generation sequencing create treatments for diseases?
In this ebook, we interview Dr Richie Kohman, Synthetic Biology Platform Lead at the Wyss Institute at Harvard, about his work with next-generation sequencing (NGS).
Artificial Intelligence solutions for healthcare delivery
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
miRNAs in brain cancer therapy – Mighty things from small beginnings grow
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
The rise of men with skin cancer: Raising awareness
We spoke to Dr Paul Banwell about the rise of men with skin cancer and how it’s vital to talk about it and raise awareness
Dr Paul Banwell is a leading plastic surgeon and highly- regarded expert in skin cancer. He is the Founder and former Head of The Melanoma...
COVID-19 infection prevention: Resource-restricted setting focus
Zisis Kozlakidis and Dewi Nur Aisyah, explain the renewed focus on resource-restricted settings when it comes to COVID-19 infection prevention
COVID vaccine: Parental hesitancy for kids with cancer
A survey shows parents of kids with cancer have similar hesitancy rates as the wider population to vaccinate their children against COVID-19.
Artificial intelligence & other cancer screening innovations
General Manager, Hologic UK and Ireland, keeps us up to speed with grasping the possibilities of AI and other innovations in cancer screening
Movember: Male cancer and mental health awareness
Wesley Baker, CEO of ANCON Medical, highlights the importance of Movember in raising awareness for male cancer, with particular focus on prostate cancer, and mental health illness.
Better prognosis identification with prostate cancer urine tests
Researchers at University of East Anglia have discovered that a prostate cancer urine test could improve the identification of men at ‘immediate risk’ of aggressive cancer, offering improved treatment methods.
Finalising a home test kit for breast cancer patients
A home test kit enabling patients with Breast cancer to test their blood nears its final development stages, with support from the NHS and inventors Entia and Pfizer.